Sight Sciences Inc. (SGHT)
NASDAQ: SGHT
· Real-Time Price · USD
3.07
0.02 (0.66%)
At close: May 01, 2025, 3:59 PM
3.08
0.33%
After-hours: May 01, 2025, 04:20 PM EDT
Company Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases.
The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists.
It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States.
The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Sight Sciences Inc.
| Country | United States |
| IPO Date | Jul 15, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 216 |
| CEO | Brenton Taylor |
Contact Details
Address: 4040 Campbell Avenue Menlo Park, California United States | |
| Website | https://www.sightsciences.com |
Stock Details
| Ticker Symbol | SGHT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001531177 |
| CUSIP Number | 82657M105 |
| ISIN Number | US82657M1053 |
| Employer ID | 80-0625749 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Brenton Taylor | Executive Vice President of Operations |
| Dr. Manohar K. Raheja Ph.D. | Executive Vice President of Research & Development |
| Dr. Reay H. Brown M.D. | Chief Medical Officer |
| Jim Rodberg | Vice President of Finance & Corporate Controller |
| Matthew W. Link | Chief Commercial Officer |
| Steve R. Tamayo Jr. | Vice President and Chief Ethics & Compliance Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2025 | 3 | Filing |
| Apr 23, 2025 | DEFA14A | Filing |
| Apr 23, 2025 | DEF 14A | Filing |
| Apr 22, 2025 | 8-K | Current Report |
| Apr 03, 2025 | 4 | Filing |
| Apr 03, 2025 | 4 | Filing |
| Apr 03, 2025 | 4 | Filing |
| Apr 03, 2025 | 4 | Filing |
| Apr 03, 2025 | 4 | Filing |
| Mar 13, 2025 | 4 | Filing |